Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+०.४७%
१,०६७.३६
+४.९६
+०.४७%
—१,०६२.४०१,०६४.१४१,०७१.९९१,०६१.०२——
SIXC
Communications
SIXC
Communications
SIXC
-०.५४%
६०३.४८
-३.२६
-०.५४%
—६०६.७४६०६.७४६०९.८४६०२.३३——
SIXE
Energy
SIXE
Energy
SIXE
+०.५४%
१,२४४.९३
+६.७२
+०.५४%
—१,२३८.२११,२३६.६०१,२४७.७४१,२३२.१०——
SIXI
Industrials
SIXI
Industrials
SIXI
+०.६८%
१,७३०.३८
+११.७७
+०.६८%
—१,७१८.६११,७२३.२३१,७४१.४८१,७१७.४७——
SIXM
Financials
SIXM
Financials
SIXM
+०.३३%
६३९.४७
+२.१०
+०.३३%
—६३७.३७६३८.२७६४२.३०६३८.२७——
SIXR
Staples
SIXR
Staples
SIXR
+०.१६%
८५४.९५
+१.३६
+०.१६%
—८५३.५९८५४.०५८५८.१९८५१.३४——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+०.११%
२१८.५६
+०.२३
+०.११%
—२१८.३३२१८.३३२१९.७३२१७.१५——
SIXT
Technology
SIXT
Technology
SIXT
+१.०२%
३,६३१.५९
+३६.७८
+१.०२%
—३,५९४.८१३,६२०.१०३,६५७.४७३,६१५.३४——
SIXU
Utilities
SIXU
Utilities
SIXU
+०.८०%
९१५.७७
+७.२३
+०.८०%
—९०८.५४९०९.५०९१७.३५९०७.०७——
SIXV
Health care
SIXV
Health care
SIXV
+१.१९%
१,५१२.८१
+१७.८१
+१.१९%
—१,४९५.००१,४९९.६११,५१७.१०१,४९९.६१——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+०.४१%
२,४०८.२१
+९.९०
+०.४१%
—२,३९८.३१२,४०६.८२२,४२१.८०२,४०४.२२——
LLY:NYSE
Eli Lilly And Co
US$ १,०६५.००
+२.२४%
(+२३.३५) 1D
मे २२, १६:००:०९ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LLY...
Open
US$ १,०४९.८१
High
US$ १,०७०.३४
Low
US$ १,०४७.०७
Mkt. cap
१०.०३ खरब
Avg. vol.
३२.४९ लाख
Volume
०.००
Dividend
०.६५%
Quarterly dividend
US$ १.७३
Ex-dividend date
२०२६ मे १५
P/E ratio
३७.८४
52-wk high
US$ १,१३३.९५
52-wk low
US$ ६२३.७८
EPS
US$ २८.१५
Beta
०.४८
Shares outstanding
९४.१७ करोड
No. of employees
५० हजार
News stories
From sources across the web
Yahoo Finance
Yahoo Finance
·
४४ मिनेट पहिले
Eli Lilly Stock Eyes Best Month This Year As Cholesterol, Obesity Drug Tailwinds Build
Gotrade
Gotrade
·
१ घण्टा पहिले
Healthcare Value Bid: LLY, UHS, THC, RXRX in Focus
The Globe and Mail
The Globe and Mail
·
२ घण्टा पहिले
Mairs & Power Inc Cuts Eli Lilly Stake by 19,039 Shares
The Globe and Mail
The Globe and Mail
·
२ घण्टा पहिले
Graham Capital Management Boosts Eli Lilly Stake by 1,869 Shares
Profile
Eli Lilly and Company, doing business as Lilly, is an American multinational pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries. The company was founded in 1876 by Eli Lilly, a pharmaceutical chemist and Union army veteran during the American Civil War for whom the company was later named. The company is ranked 4th on the list of largest biomedical companies by revenue and is the most valuable pharmaceutical company worldwide. It is ranked 100th on the Fortune 500 and 138th on the Forbes Global 2000. In November 2025, the company reached a $1 trillion market capitalization, the first health-care company in the world to do so. The company's primary products are tirzepatide for the treatment of type 2 diabetes, weight loss, and obstructive sleep apnea; abemaciclib for the treatment of advanced or metastatic breast cancers; dulaglutide for the treatment of type 2 diabetes; ixekizumab for the treatment of autoimmune diseases; and empagliflozin for the treatment of type 2 diabetes. Wikipedia
About Eli Lilly And Co
CEODavid A. Ricks
Employees५० हजार
Founded१८७६
Headquartersइन्डियानापोलिस, इन्डियाना, संयुक्त राज्य अमेरिका
Sector-
Websitelilly.com
Last report
२०२६ अप्रिल ३०
Fiscal period
Q1 2026
EPS / Est. (USD)
US$ ८.५५ / US$ ६.७९
+२५.९०%beat
Revenue / Est. (USD)
१९.८० अरब / १७.८० अरब
+११.२५%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
२०२५ जुन
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
Revenue
१५.५६ अरब
१७.६० अरब
१९.२९ अरब
१९.८० अरब
Cost of goods sold
२.४५ अरब
३.०१ अरब
३.३७ अरब
३.५८ अरब
Cost of revenue
२.४५ अरब
३.०१ अरब
३.३७ अरब
३.५८ अरब
Research and development expenses
३.३४ अरब
३.४७ अरब
३.८० अरब
३.५१ अरब
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२.६५ अरब
२.६३ अरब
३.४६ अरब
२.९३ अरब
Operating expense
५.९८ अरब
६.०९ अरब
७.२६ अरब
६.४४ अरब
Total operating expenses
८.४३ अरब
९.१० अरब
१०.६३ अरब
१०.०२ अरब
Operating income
७.१३ अरब
८.५० अरब
८.६६ अरब
९.७८ अरब
Other non operating income
-१०.१० करोड
-९१.०० लाख
१८.१२ करोड
१७.०० करोड
EBT including unusual items
६.७८ अरब
७.२३ अरब
८.२७ अरब
८.८५ अरब
EBT excluding unusual items
६.८२ अरब
८.२१ अरब
८.८९ अरब
९.७१ अरब
Income tax expense
१.१२ अरब
१.६५ अरब
१.६३ अरब
१.४५ अरब
Effective tax rate
१६.४७%
२२.८१%
१९.७०%
१६.४३%
Other operating expenses
-
-
-
-
Net income
५.६६ अरब
५.५८ अरब
६.६४ अरब
७.४० अरब
Net profit margin
३६.३८%
३१.७२%
३४.४१%
३७.३६%
Earnings per share
६.३१
७.०२
७.५४
८.५५
Interest and investment income
४.०० करोड
६.५० करोड
६७.२४ करोड
-
Interest expense
-२४.९० करोड
-१७.९६ करोड
-१५.३३ करोड
-३३.२० करोड
Net interest expenses
-२०.९० करोड
-११.४६ करोड
५१.९१ करोड
-३३.२० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
७.६० अरब
८.९७ अरब
९.२५ अरब
१०.२९ अरब
Gain or loss from assets sale
-
-
-१८.०० करोड
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer